Cargando…

Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1α)

Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase involved in cell proliferation, invasion, angiogenesis, and metastasis in various cancers, including hepatocellular carcinoma (HCC). However, the role and molecular mechanisms of EZH2 in HCC radiosensitivity remain unclear. Here, we s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Bing, Liu, Ying, Fu, Xue-Mei, Qin, Hai-Yan, Li, Gao-Kai, Wang, Hai-Chen, Sun, Shi-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444475/
https://www.ncbi.nlm.nih.gov/pubmed/36071871
http://dx.doi.org/10.1155/2022/7608712
_version_ 1784783228509356032
author Bai, Bing
Liu, Ying
Fu, Xue-Mei
Qin, Hai-Yan
Li, Gao-Kai
Wang, Hai-Chen
Sun, Shi-Long
author_facet Bai, Bing
Liu, Ying
Fu, Xue-Mei
Qin, Hai-Yan
Li, Gao-Kai
Wang, Hai-Chen
Sun, Shi-Long
author_sort Bai, Bing
collection PubMed
description Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase involved in cell proliferation, invasion, angiogenesis, and metastasis in various cancers, including hepatocellular carcinoma (HCC). However, the role and molecular mechanisms of EZH2 in HCC radiosensitivity remain unclear. Here, we show that EZH2 is upregulated in HCC cells and the aberrantly overexpressed EZH2 is associated with the poor prognosis of HCC patients. Using miRNA databases, we identified miR-138-5p as a regulator of EZH2. We also found that miR-138-5p was suppressed by EZH2-induced H3K27me3 in HCC cell lines. MiR-138-5p overexpression and EZH2 knockdown enhanced cellular radiosensitivity while inhibiting cell migration, invasion, and epithelial-mesenchymal transition (EMT). Analysis of RNA-seq datasets revealed that the hypoxia-inducible factor-1 (HIF-1) signaling pathway was the main enrichment pathway for differential genes after miR-138-5p overexpression or EZH2 knockdown. Expression level of HIF-1α was significantly suppressed after miR-138-5p overexpression or silencing of EZH2. HIF-1α silencing mitigated resistance of HCC cells and inhibited EMT. This study establishes the EZH2/miR-138-5p/HIF-1α as a potential therapeutic target for sensitizing HCC to radiotherapy.
format Online
Article
Text
id pubmed-9444475
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94444752022-09-06 Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1α) Bai, Bing Liu, Ying Fu, Xue-Mei Qin, Hai-Yan Li, Gao-Kai Wang, Hai-Chen Sun, Shi-Long Oxid Med Cell Longev Research Article Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase involved in cell proliferation, invasion, angiogenesis, and metastasis in various cancers, including hepatocellular carcinoma (HCC). However, the role and molecular mechanisms of EZH2 in HCC radiosensitivity remain unclear. Here, we show that EZH2 is upregulated in HCC cells and the aberrantly overexpressed EZH2 is associated with the poor prognosis of HCC patients. Using miRNA databases, we identified miR-138-5p as a regulator of EZH2. We also found that miR-138-5p was suppressed by EZH2-induced H3K27me3 in HCC cell lines. MiR-138-5p overexpression and EZH2 knockdown enhanced cellular radiosensitivity while inhibiting cell migration, invasion, and epithelial-mesenchymal transition (EMT). Analysis of RNA-seq datasets revealed that the hypoxia-inducible factor-1 (HIF-1) signaling pathway was the main enrichment pathway for differential genes after miR-138-5p overexpression or EZH2 knockdown. Expression level of HIF-1α was significantly suppressed after miR-138-5p overexpression or silencing of EZH2. HIF-1α silencing mitigated resistance of HCC cells and inhibited EMT. This study establishes the EZH2/miR-138-5p/HIF-1α as a potential therapeutic target for sensitizing HCC to radiotherapy. Hindawi 2022-08-29 /pmc/articles/PMC9444475/ /pubmed/36071871 http://dx.doi.org/10.1155/2022/7608712 Text en Copyright © 2022 Bing Bai et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bai, Bing
Liu, Ying
Fu, Xue-Mei
Qin, Hai-Yan
Li, Gao-Kai
Wang, Hai-Chen
Sun, Shi-Long
Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1α)
title Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1α)
title_full Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1α)
title_fullStr Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1α)
title_full_unstemmed Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1α)
title_short Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1α)
title_sort dysregulation of ezh2/mir-138-5p axis contributes to radiosensitivity in hepatocellular carcinoma cell by downregulating hypoxia-inducible factor 1 alpha (hif-1α)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444475/
https://www.ncbi.nlm.nih.gov/pubmed/36071871
http://dx.doi.org/10.1155/2022/7608712
work_keys_str_mv AT baibing dysregulationofezh2mir1385paxiscontributestoradiosensitivityinhepatocellularcarcinomacellbydownregulatinghypoxiainduciblefactor1alphahif1a
AT liuying dysregulationofezh2mir1385paxiscontributestoradiosensitivityinhepatocellularcarcinomacellbydownregulatinghypoxiainduciblefactor1alphahif1a
AT fuxuemei dysregulationofezh2mir1385paxiscontributestoradiosensitivityinhepatocellularcarcinomacellbydownregulatinghypoxiainduciblefactor1alphahif1a
AT qinhaiyan dysregulationofezh2mir1385paxiscontributestoradiosensitivityinhepatocellularcarcinomacellbydownregulatinghypoxiainduciblefactor1alphahif1a
AT ligaokai dysregulationofezh2mir1385paxiscontributestoradiosensitivityinhepatocellularcarcinomacellbydownregulatinghypoxiainduciblefactor1alphahif1a
AT wanghaichen dysregulationofezh2mir1385paxiscontributestoradiosensitivityinhepatocellularcarcinomacellbydownregulatinghypoxiainduciblefactor1alphahif1a
AT sunshilong dysregulationofezh2mir1385paxiscontributestoradiosensitivityinhepatocellularcarcinomacellbydownregulatinghypoxiainduciblefactor1alphahif1a